CONTEMPORANEOUS EXPERIENCES WITH OPPOSING STRATEGIES FOR SEVERE CONGENITAL AORTIC STENOSIS IN TWO CENTRES OVER THREE DECADES: SURGICAL VALVULOPLASTY VERSUS BALLOON VALVOTOMY  by Forsey, Jonathan et al.
Congenital Cardiology Solutions
E817
JACC March 27, 2012
Volume 59, Issue 13
CONTEMPORANEOUS EXPERIENCES WITH OPPOSING STRATEGIES FOR SEVERE CONGENITAL AORTIC 
STENOSIS IN TWO CENTRES OVER THREE DECADES: SURGICAL VALVULOPLASTY VERSUS BALLOON 
VALVOTOMY
ACC Moderated Poster Contributions
McCormick Place South, Hall A
Sunday, March 25, 2012, 11:00 a.m.-Noon
Session Title: Congenital Cardiology Solutions: Interventional Solutions
Abstract Category: 27. Congenital Cardiology Solutions: Pediatric
Presentation Number: 1136-141
Authors: Jonathan Forsey, Edward Hickey, Lee Benson, Marcus Haw, James Monro, Gruschen Veldtman, The Hospital for Sick Children, Toronto, 
Canada, Wessex Cardiovascular Centre, Southampton, United Kingdom
Background: Switching from surgical (SV) to balloon (BV) valvotomy for primary treatment of congenital aortic stenosis was not evidence-based. 
We compared outcomes between 2 tertiary centres spanning the same era who adopted opposite strategies.
Methods: Strategies were SV in centre A and BV in centre B. Competing risks and modulated renewal analysis to compare outcomes between 27 
consecutive SV (A; ‘86-’05) and 40 BV (B; ‘86-’04).
Results: Groups were identical; mean age (7 days; P=.79), weight (.29), annulus (6.4 mm; .83), LV function (.16), LV dimensions (.45) and cusps 
(.36). Mean gradients were higher in BV group (58 v 32 mmHg; P=.004). Post-procedure echo indices and valve performance were comparable 
including gradient and insufficiency. Ten years post-procedure, 8% had died, 62% undergone re-intervention and 30% were alive without re-
intervention. These proportions were not different between the groups. Risk of needing aortic valve replacement (AVR) comprised a brief EARLY (<2 
years) and rising LATE phase (>5 years) (fig). At 10 years, 23% had undergone AVR. The risk of AVR (or Ross) was not different between opposing 
strategies. In modulated renewal analysis (95 procedures on 67 patients), freedom from re-intervention was similar for BV vs SV (P=.26) (fig). 
Conclusions:  Outcomes with SV and BV appear comparable. Our results in these contemporaneous data support evidence derived from 
comparisons in non-contemporaneous data, and validate the empiric switch to primary BV approaches in the modern era.
 
